DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Research & Reports

Searching in Biopharma (1761)

24 Biopharma Reports

  • Renal Cell Carcinoma
Immune checkpoint inhibitors have entered multiple oncology indications but...
Immune checkpoint inhibitors have entered multiple oncology indications but the high costs associated with these agents present significant challenges for payers. The potential for label expansio......
Consolidation within the oncology provider community, including hospital...
Consolidation within the oncology provider community, including hospital acquisitions of oncology practices and oncology practices joining together, is changing the dynamics in the relationship b......
The success of an anticancer therapy is not only dependent on the outcome of...
The success of an anticancer therapy is not only dependent on the outcome of its pivotal trial, but also on that trial’s design, which is examined by the regulatory bodies, payers, and pres...
A Survey of Medical Oncologists and Managed Care Organization Pharmacy and...
A Survey of Medical Oncologists and Managed Care Organization Pharmacy and Medical Directors The hepatocellular carcinoma (HCC) and renal cell carcinoma (RCC) markets differ......
1 - 20 of 24